EUVIMEDEUVIMED entdecken
Open Access

Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease

Jin Ren, Yasaman J Soofi, Md Asad Rahman, Qing Lu, Jinling Liu iD

Genetic Epidemiology · 2026

DOI: 10.1002/gepi.70045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Epidemiology, 2026. Verfasst von Jin Ren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a complex neurodegenerative disorder with a significant genetic component. While genome‐wide association studies (GWAS) have been instrumental in identifying genetic variants associated with PD, the reliance on large sample sizes and population‐level analyses may overlook variants with lower minor allele frequencies or individual‐specific relevance. Individualized Bayesian Inference (IBI) offers a promising method to complement GWAS by identifying and prioritizing candidate genetic markers at both the individual and patients‐like‐me subgroup levels. This study evaluates the application of IBI to PD genetics, using GWAS as a baseline for comparison. We analyzed genetic data from the Fox Insight online study, including 8840 individuals (8585 PD cases and 255 controls). IBI prioritized variants that were not detected or were ranked substantially lower by GWAS, including variants within or near genes with prior PD association. The top 200 IBI SNPs showed stronger predictive performance in ANN models (AUC = 0.79) than the top 200 GWAS SNPs (AUC = 0.72), providing complementary support for the utility of IBI‐based prioritization in this cohort. Notably, IBI highlighted variants with lower minor allele frequencies that GWAS did not detect. This study demonstrates the utility of IBI as a complementary tool for prioritizing PD‐related candidate variants and genes for further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHumansBayes TheoremPolymorphism, Single NucleotideGenome-Wide Association StudyGene FrequencyFemaleGenetic Predisposition to DiseaseMaleAgedCase-Control StudiesGenetic VariationMiddle Aged

Autor:innen und Institutionen

  • Department of Epidemiology, University of Florida, Gainesville, Florida, USA.
  • Department of Engineering Management and Systems Engineering, Missouri University of Science and Technology, Rolla, Missouri, USA.
  • Department of Biostatistics, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Jinling Liu

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Ren, J., Soofi, Y. J., Rahman, M. A., Lu, Q., & Liu, J. (2026). Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease. Genetic Epidemiology. https://doi.org/10.1002/gepi.70045

Vancouver

Ren J, Soofi YJ, Rahman MA, Lu Q, Liu J. Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease. Genetic Epidemiology. 2026. doi:10.1002/gepi.70045

BibTeX
@article{Ren2026,
  author = {Ren, Jin and Soofi, Yasaman J and Rahman, Md Asad and Lu, Qing and Liu, Jinling},
  title = {Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease},
  journal = {Genetic Epidemiology},
  year = {2026},
  doi = {10.1002/gepi.70045}
}
Kostenlos starten →